Adaptive Research is at the forefront of revolutionizing clinical trials by bringing them closer to community practices, clinics, and hospitals. Our mission is to democratize access to clinical trials, bridging the gap between urban/rural and academic/non-academic medical practices. We partner with healthcare providers and serve as their 'Clinical Trials Office', offering comprehensive administrative, regulatory, and staffing support. Our approach accelerates patient recruitment, increases trial diversity, and reduces costs for sponsors while delivering advanced healthcare options to patients.As the CEO of Adaptive Research, I lead a team of dedicated professionals committed to transforming the way clinical trials are conducted. My role involves setting the strategic direction of the company, forging strong partnerships with healthcare providers and sponsors, and ensuring the seamless operation of our community-based clinical trials. I am constantly seeking innovative ways to streamline our processes, expand our partner network, and enhance our services, all with the goal of improving patient care and advancing medical research.I invite healthcare providers, clinical research sponsors, and anyone interested in making clinical trials more accessible and inclusive to connect with me.

Bracken supports the growth of life science firms by integrating our clients into our intelligence ecosystem. We enable you to conduct your business with broader capabilities, deeper expertise, better processes, more data, and a greater network than you had before.We provide strategic and operational guidance tailored to your needs - from ad hoc consulting to regulatory, marketing, data analytics, and C suite services. In other words, we can support your team, or we can BE your team.

Kitsa simplifies participation in clinical trials for rural hospitals, community centers, and physician practices by leveraging advanced AI tools, sponsor relationships, and site management partnerships. For established clinical trial sites, the Kitsa platform reduces staff workload and accelerates recruitment through automated patient pre-screening.

Praanatech is developing compact, affordable and high resolution PET systems. These adaptable systems can have a wide application base from neurological diseases, to oncology and particle therapy.

EPPIC Global is a comprehensive, cross-disciplinary networking group composed of professionals from a myriad of healthcare disciplines including biologists, physicians, chemists, bioengineers, and data scientists, among others. Its members are united by a common goal: to bring innovative healthcare products to patients and caregivers. EPPIC Global facilitates the convergence of technology and life sciences, driving radical new approaches to medical discovery, development, and disruption of traditional R&D. Particularly focused on the Bay Area, this platform serves as an essential hub, fostering entrepreneurship and collaboration under the theme – 'Technology meets Healthcare'. Its mission is to provide an exceptional forum for networking, mentorship, and knowledge sharing. EPPIC Global offers tangible benefits to local entrepreneurs through various initiatives such as networking events, mentorship opportunities, webinars, and the annual EPPICon conference. - Lead strategic decisions to advance the organization's mission. - Collaborate closely with high-profile executives, entrepreneurs, and thought leaders. - Foster an environment of innovation and drives broad healthcare goals. - Integral to community engagement and member professional development. - Demonstrate a strong commitment to assisting professionals within the healthcare ecosystem. - Promote a culture of collaboration and transformation within the organization.

Charter Membership at EPPIC Global represents a distinguished group of high-profile executives, entrepreneurs, and thought leaders who are dedicated to engaging with and giving back to the healthcare community. These members have achieved significant success in their professional lives and are equipped and ready to contribute to the growth and success of their fellow members. They share a strong commitment to the broad goals of the healthcare mission that transcends traditional shareholder capitalism. Charter Membership, an invitation-only position, highlights their readiness to help other professionals within the healthcare ecosystem, underlining their active role in fostering a collaborative and innovative healthcare environment.

Molecular Imaging Society of India (MISI) is a non-profit society focused on all aspects of molecular imaging in health, including functional MRI, gamma imaging, SPECT, PET, MR Spectroscopy, optical imaging, molecular ultrasound, photoacoustic imaging, radio imaging, and other emerging imaging tools. MISI is a platform for collaboration among professionals from various fields that work together to advance molecular imaging technologies and create an impact in defining and personalizing healthcare. Members include practicing clinicians, basic researchers, engineers, and industry. MISI nurtures knowledge networking to enhance the chances of impactful discoveries and progress them towards meaningful clinical practice. MISI also encourages deliberation on trends and concerns as well as participation in activities that may help shape regulations and policies to foster appropriate and effectual use of molecular imaging in healthcare.

Medical Imaging related consulting for biotech and pharmaceutical industry, academia and healthcare institutions:► Technology assessment and evaluation of medical imaging products o Scientific and technological diligence o Assessment of clinical use and impact o Evaluation of competitiveness o Path and time to regulatory approval estimation o Identifying potential value inflection points during development► Subject Matter Expertise – clinical imaging-related expertise o Strategic and operational advice o Image interpretation, analysis & validation of reading techniques o Integrate imaging into appropriate study designs for drug development o Kinetic tracer modeling, clinical biodistribution, radiation and dosimetry► Clinical Development & Regulatory Strategy o Clinical strategy and regulatory roadmap for creating evidence supporting registration and ultimate reimbursement of imaging and diagnostic products o Clinical operations support: clinical trial planning, protocol development, site & investigator selection, training of internal and external personnel o Clinical trial data analysis and interpretation, quality control o Consulting representative at FDA meetings► Medical and External Affairs o Product launch strategy & pre-launch, launch and post-launch activities o Build and lead Medical Affairs departments and teams o Medical Affairs strategies & plans to increase scientific awareness of the program, build key opinion leader relationships and champions, and advisory board activities. o Review and support investigator-sponsored trials (ISTs) o Publication strategy, and support the development of presentation and publication materials. o Product use case and market research via KOL and stakeholder interactions and focus-group interviews.► Safety and Risk management o Pharmacovigilance plan and advice o Medical monitoring

► The Indo-American Society of Nuclear Medicine (IASNM) was conceived in 1979 and incorporated as a non-profit tax-exempt organization since 1984. ► Major Objectives: - to advance the profession of nuclear medicine through exchange of ideas and knowledge among its members and other educational platforms and activities - to help promote state-of-the-art nuclear medicine in the developing countries

Lead the Medical Affairs department in a clinical development phase Biotech focused on novel imaging products enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.► Strategy, Regulatory & Medical functions o Clinical Strategy: Develop clinical & scientific strategy and roadmap for Phase I through regulatory submission o Regulatory: Close input into regulatory strategy and documents, represent company’s clinical affairs in FDA meetings and communications o Head of Pharmacovigilance: Safety surveillance plan, vendor selection and safety oversight o ISS committee chair: Strategy and management of Investigator Sponsored Studies► Clinical Development: o Lead drafting and review of clinical protocols, and other study-related documents o Cross-functional collaborations to integrate broad medical, scientific, and commercial and payor input into the development program o Lead interpretation and communication of clinical trial data o Oversee pharmacovigilance activities, including medical monitoring o Participate in operations as required – site visits for initiation, activation, enrollment enhancing activities and engagement o Clinical and medical oversight in site and vendor selection and management► External Focus and Expertise o Translate scientific/clinical content into actionable information within the company o Develop scientific materials including summary clinical data, for positioning of product with investors/Pharma partners and KOLs o Present company’s and product’s clinical data to external audiences, including pharma companies, investors, regulators and scientific audiences/conferences o Providing medical oversight to commercial collaborators & partners to support clinical trials, including study design, site selection, pharmacovigilance and safety review. o Scientific and medical advisory boards

(Life Molecular Imaging was previously Piramal Imaging)► Scientific support for Medical Affairs activities► Supporting strategic product development► In-house PET reader expert ("super-reader")► Florbetaben reader trainer ► Scientific field expert (SME) for neuro-diagnostic PET tracers in clinical practice setting ► Educate and inform medical and scientific community to enhance product knowledge and appropriate application of product in disease states► Speaker/lecturer at educational events and sessions at academic institutions (>20 presentations in 1.5 years)► Implement company’s educational program

► Oversight of regulatory compliance and finance for industry-funded clinical trials ● Institutional representative for biomedical device and pharmaceutical industry-funded clinical trials and clinical research projects ● Regulatory and financial liaison between the study team and industrial sponsor ● Clinical trial protocol review, interpretation, and application of pertinent FDA and Medicare regulations and University guidelines ● Developing budgets with coverage analysis, negotiation with sponsors, providing strategic advice to study team ● Expert consultation and oversight to ensure that sponsored research is managed and expended in compliance with internal and external policies ● Provide direction and counsel to faculty and department administrators regarding sponsored projects, and resolve compliance issues ● Expert knowledge and fluency of governmental regulations (FAR A-21, A-110, A-133, CAS, Uniform Guidelines)

Healthalyze is a innovative platform which helps measure, monitor and manage chronic lifestyle-related health conditions. It also doubles as an online medical record and connects people to their healthcare providers.► Business analysis ► Medical Liaison► Scientific Curation► Marketing

► Development and implementation of strategies in pre-clinical and clinical biomarker translational imaging research (PET, MRI, SPECT, CT, Ultrasound) ● Translation into 5 early phase clinical trials ● Two pharmaceuticals start-up companies & 3 industrial collaborations ● Two patent applications for new biomarkers/radiotracers ● More than 15 scientific articles ● Featured in scientific news and media► Presentation, communication, teaching ● Multiple presentations at international conferences, including invited presentations; 6 awards ● Guest speaker at ACS conference ● Invited lectures in registered bioengineering courses (BioE 390 & BioE 222) at Stanford ● Supervising and mentoring new team members and collaborators► Scientific medical writing and editing (in addition to 10 research journal articles) ● Two invited review articles & one solicited book chapter ● Invited to co-edit a clinical molecular imaging textbook ● Peer-reviewing for eight journals► Regulatory and compliance management ● Study protocol development, IRB and APLAC submissions, IND applications, and study reports ● Supervising compliance with safety and privacy guidelines (HIPAA, Radiation Safety, Chemical Safety, Biohazard safety, compliance guidelines and research policy)► Project and administrative management ● Leading multiple research projects and cross-functional teams throughout its life-cycle from conceptualization to completion ● Logistics management including budgeting, ordering supplies, and record keeping

► Clinical patient care ● Clinical imaging and reporting ● Areas of expertise: oncology, cardiology, neurology, nephrology, endocrinology ● I-131 Radionuclide therapy► Education and supervision ● Teaching residents, medical students, nuclear medicine technologists ● Supervising technologists ● Participation in tumor boards & molecular imaging consultation to treating clinicians► Process improvement ● Workflow optimization ● Designed and executed computerized reporting